US Supreme Court strikes Myriad blow
13-06-2013
The US District Court for the Northern District of California has found that diagnostic claims covering conventional detection methods do not make the use of a natural phenomenon patent eligible.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Myriad, diagnostic claims, Ariosa Diagnostics, Harmony test, Sequenom Inc
